Depression Cuts Adherence to COPD Maintenance Meds

Share this content:
Depression Cuts Adherence to COPD Maintenance Meds
Depression Cuts Adherence to COPD Maintenance Meds

WEDNESDAY, June 29, 2016 (HealthDay News) -- In older adults, depression is associated with decreased adherence to maintenance medication regimens for chronic obstructive pulmonary disease (COPD), according to a study published online June 22 in the Annals of the American Thoracic Society.

Jennifer S. Albrecht, Ph.D., from the University of Maryland School of Medicine in Baltimore, and colleagues examined the impact of depression on COPD maintenance medication adherence among a sample of Medicare beneficiaries newly diagnosed with COPD between 2006 and 2010. Adherence to COPD maintenance medication was modeled as a function of new episodes of depression. Data were included for 31,033 beneficiaries meeting inclusion criteria, of whom 20 percent were diagnosed with depression after diagnosis of COPD.

The researchers found that there was low average monthly adherence to COPD maintenance medications, which peaked at 57 percent in the month after first fill and declined to 35 percent within six months. Depression correlated with decreased adherence to COPD maintenance medications in an adjusted regression model (odds ratio, 0.93; 95 percent confidence interval, 0.89 to 0.98).

"Clinicians who treat older adults with COPD should be aware of the development of depression, especially during the first six months following COPD diagnosis, and monitor patients' adherence to prescribed COPD medications to ensure best clinical outcomes," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

AAN: Erenumab Shows Promise for Hard-to-Treat Migraine

AAN: Erenumab Shows Promise for Hard-to-Treat Migraine

Higher proportion of patients achieved a ≥50 percent reduction in mean monthly migraine days

AAN: New Drug May Help Infants With Spinal Muscular Atrophy

AAN: New Drug May Help Infants With Spinal ...

RG7916 increases survival motor neuron protein level, with 6.5-fold increase noted with highest dose

Small Link for Cannabis Use, Reduced Cognitive Functioning

Small Link for Cannabis Use, Reduced Cognitive Functioning

Small overall effect size for frequent and heavy cannabis use among adolescents, young adults

is free, fast, and customized just for you!

Already a member?

Sign In Now »